发明授权
- 专利标题: Methylpyrrolopyrimidinecarboxamides
- 专利标题(中): 甲基吡咯并嘧啶甲酰胺
-
申请号: US14547938申请日: 2014-11-19
-
公开(公告)号: US09376442B2公开(公告)日: 2016-06-28
- 发明人: Josef Stadlwieser , Beate Schmidt , Heiko Bernsmann , Torsten Dunkern , Ewald Benediktus , Andreas Pahl , Ragna Hussong , Olaf Nimz , Matthias Mueller , Martin Viertelhaus
- 申请人: Takeda GmbH
- 申请人地址: DE Konstanz
- 专利权人: Takeda GmbH
- 当前专利权人: Takeda GmbH
- 当前专利权人地址: DE Konstanz
- 代理机构: Nath, Goldberg & Meyer
- 代理商 Joshua B. Goldberg; Scott H. Blackman
- 优先权: EP09168685 20090826
- 主分类号: A61K31/519
- IPC分类号: A61K31/519 ; C07D487/04 ; A61P11/00
摘要:
The compounds of Formula (I), wherein R1, R2, R21, R22, R23, R24, Y and R3 have the meanings as given in the description, the salts thereof, the stereoisomers of the compounds and the salts thereof are effective inhibitors of the type 5 phosphodiesterase and are useful for treating or preventing idiopathic pulmonary lung fibrosis.
公开/授权文献
- US20150073001A1 METHYLPYRROLOPYRIMIDINECARBOXAMIDES 公开/授权日:2015-03-12